 | • レポートコード：QYR2104Z5108 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、サンドホフ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ALD-601、CCP-010、DUOC-01、MTf-HEXB、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・サンドホフ病治療の市場動向 ・企業の競争状況、市場シェア ・サンドホフ病治療の種類別市場規模（ALD-601、CCP-010、DUOC-01、MTf-HEXB、その他） ・サンドホフ病治療の用途別市場規模（クリニック、病院、その他） ・サンドホフ病治療の北米市場規模2016-2027（アメリカ、カナダ） ・サンドホフ病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・サンドホフ病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・サンドホフ病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・サンドホフ病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bioasis Technologies Inc、Nuo Therapeutics Inc） ・結論 |
Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market
The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sandhoff Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sandhoff Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sandhoff Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sandhoff Disease Therapeutics market.
Global Sandhoff Disease Therapeutics Scope and Market Size
Sandhoff Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sandhoff Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
ALD-601
CCP-010
DUOC-01
MTf-HEXB
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
レポート目次1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sandhoff Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ALD-601
1.2.3 CCP-010
1.2.4 DUOC-01
1.2.5 MTf-HEXB
1.2.6 Others
1.3 Market by Application
1.3.1 Global Sandhoff Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sandhoff Disease Therapeutics Market Perspective (2016-2027)
2.2 Sandhoff Disease Therapeutics Growth Trends by Regions
2.2.1 Sandhoff Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sandhoff Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Sandhoff Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Sandhoff Disease Therapeutics Industry Dynamic
2.3.1 Sandhoff Disease Therapeutics Market Trends
2.3.2 Sandhoff Disease Therapeutics Market Drivers
2.3.3 Sandhoff Disease Therapeutics Market Challenges
2.3.4 Sandhoff Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sandhoff Disease Therapeutics Players by Revenue
3.1.1 Global Top Sandhoff Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Sandhoff Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Sandhoff Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sandhoff Disease Therapeutics Revenue
3.4 Global Sandhoff Disease Therapeutics Market Concentration Ratio
3.4.1 Global Sandhoff Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sandhoff Disease Therapeutics Revenue in 2020
3.5 Sandhoff Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Sandhoff Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Sandhoff Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sandhoff Disease Therapeutics Breakdown Data by Type
4.1 Global Sandhoff Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Sandhoff Disease Therapeutics Forecasted Market Size by Type (2022-2027)
5 Sandhoff Disease Therapeutics Breakdown Data by Application
5.1 Global Sandhoff Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Sandhoff Disease Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sandhoff Disease Therapeutics Market Size (2016-2027)
6.2 North America Sandhoff Disease Therapeutics Market Size by Type
6.2.1 North America Sandhoff Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Sandhoff Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Sandhoff Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Sandhoff Disease Therapeutics Market Size by Application
6.3.1 North America Sandhoff Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Sandhoff Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Sandhoff Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Sandhoff Disease Therapeutics Market Size by Country
6.4.1 North America Sandhoff Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Sandhoff Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sandhoff Disease Therapeutics Market Size (2016-2027)
7.2 Europe Sandhoff Disease Therapeutics Market Size by Type
7.2.1 Europe Sandhoff Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Sandhoff Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Sandhoff Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Sandhoff Disease Therapeutics Market Size by Application
7.3.1 Europe Sandhoff Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Sandhoff Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Sandhoff Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Sandhoff Disease Therapeutics Market Size by Country
7.4.1 Europe Sandhoff Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Sandhoff Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sandhoff Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sandhoff Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sandhoff Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Sandhoff Disease Therapeutics Market Size by Type
9.2.1 Latin America Sandhoff Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Sandhoff Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Sandhoff Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Sandhoff Disease Therapeutics Market Size by Application
9.3.1 Latin America Sandhoff Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Sandhoff Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Sandhoff Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Sandhoff Disease Therapeutics Market Size by Country
9.4.1 Latin America Sandhoff Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Sandhoff Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sandhoff Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sandhoff Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bioasis Technologies Inc
11.1.1 Bioasis Technologies Inc Company Details
11.1.2 Bioasis Technologies Inc Business Overview
11.1.3 Bioasis Technologies Inc Sandhoff Disease Therapeutics Introduction
11.1.4 Bioasis Technologies Inc Revenue in Sandhoff Disease Therapeutics Business (2016-2021)
11.1.5 Bioasis Technologies Inc Recent Development
11.2 Nuo Therapeutics Inc
11.2.1 Nuo Therapeutics Inc Company Details
11.2.2 Nuo Therapeutics Inc Business Overview
11.2.3 Nuo Therapeutics Inc Sandhoff Disease Therapeutics Introduction
11.2.4 Nuo Therapeutics Inc Revenue in Sandhoff Disease Therapeutics Business (2016-2021)
11.2.5 Nuo Therapeutics Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sandhoff Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ALD-601
Table 3. Key Players of CCP-010
Table 4. Key Players of DUOC-01
Table 5. Key Players of MTf-HEXB
Table 6. Key Players of Others
Table 7. Global Sandhoff Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Sandhoff Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Sandhoff Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Sandhoff Disease Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Sandhoff Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Sandhoff Disease Therapeutics Market Share by Regions (2022-2027)
Table 13. Sandhoff Disease Therapeutics Market Trends
Table 14. Sandhoff Disease Therapeutics Market Drivers
Table 15. Sandhoff Disease Therapeutics Market Challenges
Table 16. Sandhoff Disease Therapeutics Market Restraints
Table 17. Global Sandhoff Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Sandhoff Disease Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Sandhoff Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sandhoff Disease Therapeutics as of 2020)
Table 20. Ranking of Global Top Sandhoff Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Sandhoff Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sandhoff Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Sandhoff Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Sandhoff Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Sandhoff Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Sandhoff Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Sandhoff Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Sandhoff Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Sandhoff Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Sandhoff Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Sandhoff Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Sandhoff Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Sandhoff Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Sandhoff Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Sandhoff Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Sandhoff Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Sandhoff Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Sandhoff Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Sandhoff Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Sandhoff Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Sandhoff Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Sandhoff Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Sandhoff Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Sandhoff Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Sandhoff Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Sandhoff Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Sandhoff Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bioasis Technologies Inc Company Details
Table 65. Bioasis Technologies Inc Business Overview
Table 66. Bioasis Technologies Inc Sandhoff Disease Therapeutics Product
Table 67. Bioasis Technologies Inc Revenue in Sandhoff Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Bioasis Technologies Inc Recent Development
Table 69. Nuo Therapeutics Inc Company Details
Table 70. Nuo Therapeutics Inc Business Overview
Table 71. Nuo Therapeutics Inc Sandhoff Disease Therapeutics Product
Table 72. Nuo Therapeutics Inc Revenue in Sandhoff Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Nuo Therapeutics Inc Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sandhoff Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. ALD-601 Features
Figure 3. CCP-010 Features
Figure 4. DUOC-01 Features
Figure 5. MTf-HEXB Features
Figure 6. Others Features
Figure 7. Global Sandhoff Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Sandhoff Disease Therapeutics Report Years Considered
Figure 12. Global Sandhoff Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Sandhoff Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sandhoff Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Sandhoff Disease Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Sandhoff Disease Therapeutics Market Share by Players in 2020
Figure 17. Global Top Sandhoff Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sandhoff Disease Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Sandhoff Disease Therapeutics Revenue in 2020
Figure 19. Global Sandhoff Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Sandhoff Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Sandhoff Disease Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Sandhoff Disease Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Sandhoff Disease Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Sandhoff Disease Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Sandhoff Disease Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Sandhoff Disease Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Sandhoff Disease Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Sandhoff Disease Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Sandhoff Disease Therapeutics Market Share by Region (2016-2027)
Figure 41. China Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Sandhoff Disease Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Sandhoff Disease Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Sandhoff Disease Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Sandhoff Disease Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Sandhoff Disease Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Sandhoff Disease Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Sandhoff Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bioasis Technologies Inc Revenue Growth Rate in Sandhoff Disease Therapeutics Business (2016-2021)
Figure 61. Nuo Therapeutics Inc Revenue Growth Rate in Sandhoff Disease Therapeutics Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
世界の非アルコール性脂肪肝疾患治療薬市場規模・現状・予測（2021年-2027年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …- 世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Bowel Disease Therapeutics Market The global Inflammatory Bowel Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…
- 世界の胃食道逆流症（GERD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-stand…
- 世界のフォンウィルブランド病（VWD）治療薬市場規模・現状・予測（2021年-2027年） Von Willebrand Disease is an inherited bleeding disorder that is caused by deficiency or dysfunction of Von Willebrand Factor (VWF). VWF is a plasma protein that mediates the initial adhesion of platelets at sites of vascular injury. This protein also binds to clotting factor VIII (FVIII) in the cir…